MedPath

A study and Exploratory Clinical trial on chronological changes of the Iomazenil SPECT in coping with Higher brain dysfunction after cerebral trauma

Not Applicable
Conditions
Higher brain dysfunction following traumatic brain injury
Registration Number
JPRN-UMIN000021732
Lead Sponsor
Hokkaido University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

(1) The patients who cannot discontinue benzodiazepine drugs for one week (2) The patients who cannot conduct various tests such as nerve psychological tests (3) The patients with a history of other mental disorder and neurologic disease (4) The patient with serious liver dysfunction, serious renal dysfunction, or dysuria (5) In addition, the patient whom a study person in charge judged to be inadequate as subjects

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<Efficacy> Presence or absence of changes of IMZ-SPECT one year later
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath